Exosomes Derived from MiR-92a-3p-overexpressing Human Mesenchymal Stem Cells Enhance Chondrogenesis and Suppress Cartilage Degradation Via Targeting WNT5A
Overview
Affiliations
Background: WNT5A is known to be involved in the pathogenesis of osteoarthritis. This study investigated the molecular mechanism of exosomal miR-92a-3p and WNT5A in chondrogenesis and cartilage degeneration.
Methods: Exosomal miR-92a-3p expression was assessed in vitro in a human mesenchymal stem cell (MSC) model of chondrogenesis and in normal and OA primary human chondrocytes (PHCs). MSCs and PHCs were treated with exosomes derived from MSC-miR-92a-3p (MSC-miR-92a-3p-Exos) or its antisense inhibitor (MSC-anti-miR-92a-3p-Exos), respectively. Small interfering RNAs (siRNAs) and luciferase reporter assay were used to reveal the molecular role of exosomal miR-92a-3p and WNT5A in chondrogenesis. The protective effect of exosomes in vivo was measured using Safranin-O and Fast Green staining and immunohistochemical staining.
Results: Exosomal miR-92a-3p expression was elevated in the MSC chondrogenic exosome, while it was significantly reduced in the OA chondrocyte-secreted exosome compared with normal cartilage. Treatment with MSC-miR-92a-3p-Exos promoted cartilage proliferation and matrix genes expression in MSCs and PHCs, respectively. In contrast, treatment with MSC-anti-miR-92a-3p-Exos repressed chondrogenic differentiation and reduced cartilage matrix synthesis by enhancing the expression of WNT5A. Luciferase reporter assay demonstrated that miR-92a-3p suppressed the activity of a reporter construct containing the 3'-UTR and inhibited WNT5A expression in both MSCs and PHCs. MSC-miR-92a-3p-Exos inhibit cartilage degradation in the OA mice model.
Conclusions: Our results suggest that exosomal miR-92a-3p regulates cartilage development and homeostasis by directly targeting WNT5A. This indicates that exosomal miR-92a-3p may act as a Wnt inhibitor and exhibits potential as a disease-modifying osteoarthritis drug.
Zhang C, Zhou T, Qiao S, Lu L, Zhu M, Wang A Mol Neurobiol. 2025; .
PMID: 40085353 DOI: 10.1007/s12035-025-04819-3.
Pakdaman Kolour S, Nematollahi S, Dehbozorgi M, Fattahi F, Movahed F, Esfandiari N Heliyon. 2025; 11(3):e42258.
PMID: 40007782 PMC: 11850152. DOI: 10.1016/j.heliyon.2025.e42258.
Wang P, Zhao H, Chen W, Guo Y, Zhang S, Xing X J Tissue Eng. 2025; 16:20417314241312563.
PMID: 39926048 PMC: 11806476. DOI: 10.1177/20417314241312563.
Exosomal miRNAs involvement in pathogenesis, diagnosis, and treatment of rheumatoid arthritis.
Sadeghi M, Tavakol Afshari J, Fadaee A, Dashti M, Kheradmand F, Dehnavi S Heliyon. 2025; 11(2):e41983.
PMID: 39897907 PMC: 11786886. DOI: 10.1016/j.heliyon.2025.e41983.
Ciesla J, Tomsia M Histochem Cell Biol. 2025; 163(1):27.
PMID: 39863760 DOI: 10.1007/s00418-025-02356-7.